Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Profile, Phenotypes, and Risk Stratification. A Narrative Review
Journal of Biochemical Technology · 2026 · 17 (2) · 30-44
DOI: 10.51847/ybhmiqqb3d ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical Technology, 2026. Verfasst von Zalina Yuryevna Sozaeva und 9 weiteren Autor:innen. Die Arbeit nennt 126 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sozaeva, Z. Y., Atayeva, M. V., Salatova, E. O., Alikova, I. K., Dolgaya, A. E., Magomedov, A. G., Hafsi, K. R., Shomakhov, N. A., Pshukova, E. M., & Sharaf, Y. N. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Profile, Phenotypes, and Risk Stratification. A Narrative Review. Journal of Biochemical Technology, 17(2), 30-44. https://doi.org/10.51847/ybhmiqqb3d
Vancouver
Sozaeva ZY, Atayeva MV, Salatova EO, Alikova IK, Dolgaya AE, Magomedov AG, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Profile, Phenotypes, and Risk Stratification. A Narrative Review. Journal of Biochemical Technology. 2026;17(2):30-44. doi:10.51847/ybhmiqqb3d
BibTeX
@article{Sozaeva2026,
author = {Sozaeva, Zalina Yuryevna and Atayeva, Marina Vsevolodovna and Salatova, Elizaveta Olegovna and Alikova, Irina Kazbekovna and Dolgaya, Alexandra Evgenievna and Magomedov, Amin Gasaevich and Hafsi, Kamilla Ramisovna and Shomakhov, Nur-Mukhamed Aslanovich and Pshukova, Elena Mukhadinovna and Sharaf, Yulia Nikolaevna},
title = {Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Clinical Profile, Phenotypes, and Risk Stratification. A Narrative Review},
journal = {Journal of Biochemical Technology},
year = {2026},
volume = {17},
number = {2},
pages = {30--44},
doi = {10.51847/ybhmiqqb3d}
}
EUVIMED